Cancer Genetics has merged with StemoniX and is addressing the challenges of drug discovery using innovative, science-based technologies and a highly-developed focus on the regulatory community.
FOUNDER AND CEO & PRESIDENT AND CHIEF OF BUSINESS AND STRATEGY, PURETECH HEALTH
PureTech Health is expanding swiftly with 24 product candidates that it has invented or initiated, 13 of which are in clinical testing, and two have received FDA clearance.
"Much of the focus of tech development has been for people in IT and data science. This creates a big barrier to adoption for chemists, biologists or chemical engineers, it is unsustainable. Overcoming those two barriers is the inspiration behind Quartic.ai."
Ontario Mining and Toronto's Global Reach 2024 - Digital Interactive
GBR’s annual Ontario Mining and Toronto’s Global Reach 2024 report draws from over 100 interviews with leading executives from major producers, associations, juniors, consultants, investors, and service providers, to provide an in-depth and holistic view of what is happening now, and more pertinently, what could happen in the years ahead.